BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7800087)

  • 1. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodromal symptoms and prevention of relapse in schizophrenia.
    Herz M
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):22-5. PubMed ID: 2865253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relapse in schizophrenia: an exploratory study of the joint conceptions of patients, parents and caregivers].
    Koenig M; Castillo MC; Urdapilleta I; Le Borgne P; Bouleau JH
    Encephale; 2011 Jun; 37(3):207-16. PubMed ID: 21703436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response of prophylactic antipsychotics.
    Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
    J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression in the early course of schizophrenia].
    Bustamante S; Maurer K; Löffler W; Häfner H
    Fortschr Neurol Psychiatr; 1994 Sep; 62(9):317-29. PubMed ID: 7959515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromes of first-episode psychosis: how can we challenge nonspecificity?
    Simon AE; Ferrero FP; Merlo MC
    Compr Psychiatry; 2001; 42(5):382-92. PubMed ID: 11559865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prodromes of schizophrenia recurrence].
    Bottai T; Cotton I; Drigeard A; Vaglio V
    Encephale; 2009 Jan; 35 Suppl 1():S33-40. PubMed ID: 19268166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
    Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
    Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
    J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, targeted pharmacotherapeutic intervention in schizophrenia.
    Carpenter W
    J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long prodromal phase in schizophrenia. By recognizing it, the prognosis of the patient can be significantly improved].
    Löffler W; Häfner H
    MMW Fortschr Med; 2000 Mar; 142(10):26-9. PubMed ID: 10748599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team - final results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Sep; 19(3):130-8. PubMed ID: 17914313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.